| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 12 |
| 1 | GABAPENTIN | 6 |
| 2 | SOFOSBUVIR | 6 |
| 3 | LEDIPASVIR AND SOFOSBUVIR | 5 |
| 4 | METHADONE | 5 |
| 5 | METHADONE HYDROCHLORIDE | 5 |
| 6 | MYCOPHENOLATE MOFETIL | 5 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 5 |
| 8 | LOXAPINE | 4 |
| 9 | METHYLPHENIDATE HYDROCHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOXAPINE | 4 | 0.0010 |
| 1 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 2 | METHADONE HYDROCHLORIDE | 5 | 0.0005 |
| 3 | VELPATASVIR AND SOFOSBUVIR | 4 | 0.0003 |
| 4 | SOFOSBUVIR | 6 | 0.0003 |
| 5 | ESLICARBAZEPINE ACETATE | 1 | 0.0003 |
| 6 | LEDIPASVIR AND SOFOSBUVIR | 5 | 0.0003 |
| 7 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 8 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| 9 | RIBAVIRIN | 12 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 15 | 0.0003 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 11 | 0.0002 |
| 2 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 3 | 0.0002 |
| 3 | Nucleoside Analog Antiviral [EPC] | 13 | 0.0002 |
| 4 | Central Nervous System Stimulant [EPC] | 4 | 0.0000 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |